Liraglutide for management of adolescent obesity

Affiliations

¹ Child Growth and Development Research Center, Research Institute for Primordial Prevention of Non-Communicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran. Kelishadi@med.mui.ac.ir.

Comment

Roya Kelishadi. Nat Rev Endocrinol. 2020 Aug.

. 2020 Aug;16(8):405-406.

doi: 10.1038/s41574-020-0371-7.

¹ Child Growth and Development Research Center, Research Institute for Primordial Prevention of Non-Communicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran. Kelishadi@med.mui.ac.ir.

No abstract available

Comment on

A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity.
Kelly AS, Auerbach P, Barrientos-Perez M, Gies I, Hale PM, Marcus C, Mastrandrea LD, Prabhu N, Arslanian S; NN8022-4180 Trial Investigators. Kelly AS, et al. N Engl J Med. 2020 May 28;382(22):2117-2128. doi: 10.1056/NEJMoa1916038. Epub 2020 Mar 31. N Engl J Med. 2020. PMID: 32233338 Clinical Trial.

1. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults. Lancet 390, 2627–2642 (2017). - DOI
1. Kelishadi, R. et al. Controlling childhood obesity: A systematic review on strategies and challenges. J. Res. Med. Sci. 19, 993–1008 (2014). - PubMed - PMC
1. Bahia, L. et al. Overview of meta-analysis on prevention and treatment of childhood obesity. J. Pediatr. 95, 385–400 (2019). - DOI
1. Srivastava, G. et al. Clinical considerations regarding the use of obesity pharmacotherapy in adolescents with obesity. Obesity (Silver Spring) 27, 190–204 (2019). - DOI
1. Anderson, K. L. A review of the prevention and medical management of childhood obesity. Child Adolesc. Psychiatr. Clin. N. Am. 27, 63–76 (2018). - DOI